BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Santos SF, de Oliveira HL, Yamada ES, Neves BC, Pereira A Jr. The Gut and Parkinson's Disease-A Bidirectional Pathway. Front Neurol 2019;10:574. [PMID: 31214110 DOI: 10.3389/fneur.2019.00574] [Cited by in Crossref: 75] [Cited by in F6Publishing: 80] [Article Influence: 25.0] [Reference Citation Analysis]
Number Citing Articles
1 He Z, Huan P, Wang L, He J. Compound Dihuang Granule Changes Gut Microbiota of MPTP-Induced Parkinson's Disease Mice via Inhibiting TLR4/NF-κB Signaling.. [DOI: 10.21203/rs.3.rs-2300112/v1] [Reference Citation Analysis]
2 Claudino dos Santos JC, Lima MPP, Brito GADC, Viana GSDB. ROLE OF ENTERIC GLIA AND MICROBIOTA-GUT-BRAIN AXIS IN PARKINSON DISEASE PATHOGENESIS. Ageing Research Reviews 2022. [DOI: 10.1016/j.arr.2022.101812] [Reference Citation Analysis]
3 Han Y, Wang B, Gao H, He C, Hua R, Liang C, Zhang S, Wang Y, Xin S, Xu J. Vagus Nerve and Underlying Impact on the Gut Microbiota-Brain Axis in Behavior and Neurodegenerative Diseases. JIR 2022;Volume 15:6213-6230. [DOI: 10.2147/jir.s384949] [Reference Citation Analysis]
4 Cuevas-carbonell SG, Vásquez-celaya L, García-lópez D, Granados-patrón D, del R. García-miss M, Álvarez-cervera FJ, Mut-martín M, Parra I, Mendieta L, Salgado H, Alamilla J, Cruz-bojórquez R, Luisa Ávila-escalante M, Aranda-gonzález II, Góngora-alfaro JL. Chronic treatment with the probiotics Lacticaseibacillus rhamnosus GG and Bifidobacterium lactis BB12 attenuates motor impairment, striatal microglial activation, and dopaminergic loss in rats with 6-hydroxydopamine-induced hemiparkinsonism. Neuroscience 2022. [DOI: 10.1016/j.neuroscience.2022.11.004] [Reference Citation Analysis]
5 Chan DG, Ventura K, Villeneuve A, Du Bois P, Holahan MR. Exploring the Connection Between the Gut Microbiome and Parkinson’s Disease Symptom Progression and Pathology: Implications for Supplementary Treatment Options. JPD 2022. [DOI: 10.3233/jpd-223461] [Reference Citation Analysis]
6 Biazzo M, Allegra M, Deidda G. Clostridioides difficile and neurological disorders: New perspectives. Front Neurosci 2022;16:946601. [DOI: 10.3389/fnins.2022.946601] [Reference Citation Analysis]
7 Bhidayasiri R, Phuenpathom W, Tan AH, Leta V, Phumphid S, Chaudhuri KR, Pal PK. Management of dysphagia and gastroparesis in Parkinson’s disease in real-world clinical practice – Balancing pharmacological and non-pharmacological approaches. Front Aging Neurosci 2022;14:979826. [DOI: 10.3389/fnagi.2022.979826] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Kim H, Jeon S, Kim J, Seol D, Jo J, Cho S, Kim H. Investigation of memory-enhancing effects of Streptococcus thermophilus EG007 in mice and elucidating molecular and metagenomic characteristics using nanopore sequencing. Sci Rep 2022;12:13274. [PMID: 35918353 DOI: 10.1038/s41598-022-14837-z] [Reference Citation Analysis]
9 Klæstrup IH, Just MK, Holm KL, Alstrup AKO, Romero-ramos M, Borghammer P, Van Den Berge N. Impact of aging on animal models of Parkinson's disease. Front Aging Neurosci 2022;14:909273. [DOI: 10.3389/fnagi.2022.909273] [Reference Citation Analysis]
10 Wang J, Yang X, Zeng W, Zhang X, Yang X, Xu Y, Liu K, Zhang Z, Xu Y, Cao X. Dual Effects: Intrastriatal Injection of α-syn N103/tau N368 Preformed Fibrils Promotes Endogenous α-synuclein Aggregates in the Proximal Colon. J Parkinsons Dis 2022. [PMID: 35912751 DOI: 10.3233/JPD-223294] [Reference Citation Analysis]
11 Gama J, Neves B, Pereira A. Chronic Effects of Dietary Pesticides on the Gut Microbiome and Neurodevelopment. Front Microbiol 2022;13:931440. [PMID: 35847088 DOI: 10.3389/fmicb.2022.931440] [Reference Citation Analysis]
12 Yang R, Gao G, Yang H. The Pathological Mechanism Between the Intestine and Brain in the Early Stage of Parkinson's Disease. Front Aging Neurosci 2022;14:861035. [DOI: 10.3389/fnagi.2022.861035] [Reference Citation Analysis]
13 Li Y, Peng Y, Shen Y, Zhang Y, Liu L, Yang X. Dietary polyphenols: regulate the advanced glycation end products-RAGE axis and the microbiota-gut-brain axis to prevent neurodegenerative diseases. Crit Rev Food Sci Nutr 2022;:1-27. [PMID: 35587161 DOI: 10.1080/10408398.2022.2076064] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Song B, Feldmann JW, Cao S, Feitosa M, Kong Y, Kim W, Schweitzer A, Leblanc P, Schweitzer JS, Kim K. A Pitx3-deficient developmental mouse model for fine motor, olfactory, and gastrointestinal symptoms of Parkinson's disease. Neurobiology of Disease 2022. [DOI: 10.1016/j.nbd.2022.105777] [Reference Citation Analysis]
15 Cenci A, Macchia I, La Sorsa V, Sbarigia C, Di Donna V, Pietraforte D. Mechanisms of Action of Ozone Therapy in Emerging Viral Diseases: Immunomodulatory Effects and Therapeutic Advantages With Reference to SARS-CoV-2. Front Microbiol 2022;13:871645. [DOI: 10.3389/fmicb.2022.871645] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
16 Li YY, Zhou TT, Zhang Y, Chen NH, Yuan YH. Distribution of α-Synuclein Aggregation in the Peripheral Tissues. Neurochem Res 2022. [PMID: 35348944 DOI: 10.1007/s11064-022-03586-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
17 Alfonsetti M, Castelli V, d'Angelo M. Are We What We Eat? Impact of Diet on the Gut-Brain Axis in Parkinson's Disease. Nutrients 2022;14:380. [PMID: 35057561 DOI: 10.3390/nu14020380] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
18 Kim H, Bae C, Kim J, Lee Y, Jeon H, Kim H, Kim S. Rumex japonicus Houtt. Protects Dopaminergic Neurons by Regulating Mitochondrial Function and Gut–Brain Axis in In Vitro and In Vivo Models of Parkinson’s Disease. Antioxidants 2022;11:141. [DOI: 10.3390/antiox11010141] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
19 Ghyselinck J, Verstrepen L, Moens F, Van Den Abbeele P, Bruggeman A, Said J, Smith B, Barker LA, Jordan C, Leta V, Chaudhuri KR, Basit AW, Gaisford S. Influence of probiotic bacteria on gut microbiota composition and gut wall function in an in-vitro model in patients with Parkinson's disease. Int J Pharm X 2021;3:100087. [PMID: 34977556 DOI: 10.1016/j.ijpx.2021.100087] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 6.0] [Reference Citation Analysis]
20 Abonahas HH, El-maradny YA, Gezaf SA, Abo Nouh FA, Abonahas YH, Landa-acuña D, Gil-polo A, Saied EM, Abdel-azeem AM. Virome and Microbiome Interaction and Their Implication in the Human Gut Health. Microbiome-Gut-Brain Axis 2022. [DOI: 10.1007/978-981-16-1626-6_4] [Reference Citation Analysis]
21 Ramachandra VH, Sivanesan S, Koppal A, Anandakumar S, Howell MD, Sukumar E, Vijayaraghavan R. Embelin and levodopa combination therapy for improved Parkinson's disease treatment. Transl Neurosci 2022;13:145-62. [PMID: 35855085 DOI: 10.1515/tnsci-2022-0224] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
22 Jena R, Jain R, Muralidharan S, Yanamala VL, Zubair Z, Kantamaneni K, Jalla K, Renzu M, Alfonso M. Role of Gastrointestinal Dysbiosis and Fecal Transplantation in Parkinson's Disease. Cureus 2021;13:e19035. [PMID: 34853754 DOI: 10.7759/cureus.19035] [Reference Citation Analysis]
23 Derkinderen P, Cossais F, de Guilhem de Lataillade A, Leclair-Visonneau L, Neunlist M, Paillusson S, De Giorgio R. Gastrointestinal mucosal biopsies in Parkinson's disease: beyond alpha-synuclein detection. J Neural Transm (Vienna) 2021. [PMID: 34816335 DOI: 10.1007/s00702-021-02445-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
24 Deidda G, Biazzo M. Gut and Brain: Investigating Physiological and Pathological Interactions Between Microbiota and Brain to Gain New Therapeutic Avenues for Brain Diseases. Front Neurosci 2021;15:753915. [PMID: 34712115 DOI: 10.3389/fnins.2021.753915] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 9.0] [Reference Citation Analysis]
25 Ilie OD, Paduraru E, Robea MA, Balmus IM, Jijie R, Nicoara M, Ciobica A, Nita IB, Dobrin R, Doroftei B. The Possible Role of Bifidobacterium longum BB536 and Lactobacillus rhamnosus HN001 on Locomotor Activity and Oxidative Stress in a Rotenone-Induced Zebrafish Model of Parkinson's Disease. Oxid Med Cell Longev 2021;2021:9629102. [PMID: 34691361 DOI: 10.1155/2021/9629102] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
26 Hill AE, Wade-Martins R, Burnet PWJ. What Is Our Understanding of the Influence of Gut Microbiota on the Pathophysiology of Parkinson's Disease? Front Neurosci 2021;15:708587. [PMID: 34512244 DOI: 10.3389/fnins.2021.708587] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
27 Peterson CT. Dysfunction of the Microbiota-Gut-Brain Axis in Neurodegenerative Disease: The Promise of Therapeutic Modulation With Prebiotics, Medicinal Herbs, Probiotics, and Synbiotics. J Evid Based Integr Med 2020;25:2515690X20957225. [PMID: 33092396 DOI: 10.1177/2515690X20957225] [Cited by in Crossref: 24] [Cited by in F6Publishing: 30] [Article Influence: 24.0] [Reference Citation Analysis]
28 Timmers ER, van Faassen M, Smit M, Kuiper A, Hof IH, Kema IP, Tijssen MAJ, Niezen-Koning KE, de Koning TJ. Dopaminergic and serotonergic alterations in plasma in three groups of dystonia patients. Parkinsonism Relat Disord 2021;91:48-54. [PMID: 34482194 DOI: 10.1016/j.parkreldis.2021.08.019] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
29 Brendza R, Lin H, Stark K, Foreman O, Tao J, Pierce A, Ngu H, Shen K, Easton AE, Bhangale T, Chang D, Bingol B, Friedman BA. Genetic ablation of Gpnmb does not alter synuclein-related pathology. Neurobiol Dis 2021;159:105494. [PMID: 34464706 DOI: 10.1016/j.nbd.2021.105494] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
30 Lei Q, Wu T, Wu J, Hu X, Guan Y, Wang Y, Yan J, Shi G. Roles of α‑synuclein in gastrointestinal microbiome dysbiosis‑related Parkinson's disease progression (Review). Mol Med Rep 2021;24:734. [PMID: 34414447 DOI: 10.3892/mmr.2021.12374] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
31 Devault KR, Achem SR. Esophageal Disease in Older Patients. The Esophagus 2021. [DOI: 10.1002/9781119599692.ch47] [Reference Citation Analysis]
32 Koppel K, Tang H, Javed I, Parsa M, Mortimer M, Davis TP, Lin S, Chaffee AL, Ding F, Ke PC. Elevated amyloidoses of human IAPP and amyloid beta by lipopolysaccharide and their mitigation by carbon quantum dots. Nanoscale 2020;12:12317-28. [PMID: 32490863 DOI: 10.1039/d0nr02710c] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 18.0] [Reference Citation Analysis]
33 Zilber-Rosenberg I, Rosenberg E. Microbial driven genetic variation in holobionts. FEMS Microbiol Rev 2021:fuab022. [PMID: 33930136 DOI: 10.1093/femsre/fuab022] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 8.0] [Reference Citation Analysis]
34 Metta V, Leta V, Mrudula KR, Prashanth LK, Goyal V, Borgohain R, Chung-Faye G, Chaudhuri KR. Gastrointestinal dysfunction in Parkinson's disease: molecular pathology and implications of gut microbiome, probiotics, and fecal microbiota transplantation. J Neurol 2021. [PMID: 33881598 DOI: 10.1007/s00415-021-10567-w] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 16.0] [Reference Citation Analysis]
35 Van Den Berge N, Ferreira N, Mikkelsen TW, Alstrup AKO, Tamgüney G, Karlsson P, Terkelsen AJ, Nyengaard JR, Jensen PH, Borghammer P. Ageing promotes pathological alpha-synuclein propagation and autonomic dysfunction in wild-type rats. Brain 2021;144:1853-68. [PMID: 33880502 DOI: 10.1093/brain/awab061] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 30.0] [Reference Citation Analysis]
36 Burgos-Blasco B, Güemes-Villahoz N, Vidal-Villegas B, Martinez-de-la-Casa JM, Donate-Lopez J, Martín-Sánchez FJ, González-Armengol JJ, Porta-Etessam J, Martin JLR, Garcia-Feijoo J. Optic nerve and macular optical coherence tomography in recovered COVID-19 patients. Eur J Ophthalmol 2021;:11206721211001019. [PMID: 33719624 DOI: 10.1177/11206721211001019] [Cited by in Crossref: 6] [Cited by in F6Publishing: 10] [Article Influence: 6.0] [Reference Citation Analysis]
37 Dogra N, Mani RJ, Katare DP. The Gut-Brain Axis: Two Ways Signaling in Parkinson's Disease. Cell Mol Neurobiol 2021. [PMID: 33649989 DOI: 10.1007/s10571-021-01066-7] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 14.0] [Reference Citation Analysis]
38 Yu Z, Li Y; and the Parkinson's Progression Markers Initiative. Association of autonomic symptoms with cerebrospinal fluid biomarkers in Parkinson disease and scans without evidence of dopaminergic deficit. Medicine (Baltimore) 2021;100:e24837. [PMID: 33607852 DOI: 10.1097/MD.0000000000024837] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
39 Kumaresan M, Khan S. Spectrum of Non-Motor Symptoms in Parkinson's Disease. Cureus 2021;13:e13275. [PMID: 33728210 DOI: 10.7759/cureus.13275] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
40 Metz CN, Pavlov VA. Treating disorders across the lifespan by modulating cholinergic signaling with galantamine. J Neurochem 2021;158:1359-80. [PMID: 33219523 DOI: 10.1111/jnc.15243] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 11.0] [Reference Citation Analysis]
41 Rani L, Mondal AC. Unravelling the role of gut microbiota in Parkinson's disease progression: Pathogenic and therapeutic implications. Neurosci Res 2021;168:100-12. [PMID: 33417973 DOI: 10.1016/j.neures.2021.01.001] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 9.0] [Reference Citation Analysis]
42 Rajput C, Sarkar A, Sachan N, Rawat N, Singh MP. Is Gut Dysbiosis an Epicenter of Parkinson's Disease? Neurochem Res 2021;46:425-38. [PMID: 33400024 DOI: 10.1007/s11064-020-03187-9] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 7.0] [Reference Citation Analysis]
43 Rosenberg E. Dynamics of Microbiomes. Microbiomes 2021. [DOI: 10.1007/978-3-030-65317-0_3] [Reference Citation Analysis]
44 Castelli V, d'Angelo M, Quintiliani M, Benedetti E, Cifone MG, Cimini A. The emerging role of probiotics in neurodegenerative diseases: new hope for Parkinson's disease? Neural Regen Res 2021;16:628-34. [PMID: 33063712 DOI: 10.4103/1673-5374.295270] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 23.0] [Reference Citation Analysis]
45 Singh Y, Trautwein C, Romani J, Salker MS, Neckel PH, Fraccaroli I, Abeditashi M, Woerner N, Admard J, Dhariwal A, Dueholm MS, Schäfer K, Lang F, Otzen D, Lashuel HA, Riess O, Casadei N. Overexpression of human alpha-Synuclein leads to dysregulated microbiome/metabolites with ageing in a rat model of Parkinson disease.. [DOI: 10.1101/2020.12.23.424226] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
46 Nagu P, Parashar A, Behl T, Mehta V. CNS implications of COVID-19: a comprehensive review. Rev Neurosci 2021;32:219-34. [PMID: 33550782 DOI: 10.1515/revneuro-2020-0070] [Cited by in Crossref: 41] [Cited by in F6Publishing: 43] [Article Influence: 20.5] [Reference Citation Analysis]
47 Tan JSY, Chao YX, Rötzschke O, Tan EK. New Insights into Immune-Mediated Mechanisms in Parkinson's Disease. Int J Mol Sci 2020;21:E9302. [PMID: 33291304 DOI: 10.3390/ijms21239302] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
48 Gazerani P. Venoms as an adjunctive therapy for Parkinson's disease: where are we now and where are we going? Future Sci OA 2020;7:FSO642. [PMID: 33437512 DOI: 10.2144/fsoa-2020-0119] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
49 Albaret G, Sifré E, Floch P, Laye S, Aubert A, Dubus P, Azzi-Martin L, Giese A, Salles N, Mégraud F, Varon C, Lehours P, Roubaud-Baudron C. Alzheimer's Disease and Helicobacter pylori Infection: Inflammation from Stomach to Brain? J Alzheimers Dis 2020;73:801-9. [PMID: 31868664 DOI: 10.3233/JAD-190496] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 9.0] [Reference Citation Analysis]
50 Perez Visñuk D, Savoy de Giori G, Leblanc JG, de Moreno de LeBlanc A. Neuroprotective effects associated with immune modulation by selected lactic acid bacteria in a Parkinson's disease model. Nutrition 2020;79-80:110995. [DOI: 10.1016/j.nut.2020.110995] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 7.0] [Reference Citation Analysis]
51 Shahbazi R, Yasavoli-Sharahi H, Alsadi N, Ismail N, Matar C. Probiotics in Treatment of Viral Respiratory Infections and Neuroinflammatory Disorders. Molecules 2020;25:E4891. [PMID: 33105830 DOI: 10.3390/molecules25214891] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 14.0] [Reference Citation Analysis]
52 Angelopoulou E, Paudel YN, Piperi C. Emerging role of S100B protein implication in Parkinson's disease pathogenesis. Cell Mol Life Sci 2021;78:1445-53. [PMID: 33052436 DOI: 10.1007/s00018-020-03673-x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
53 Singh Y, Trautwein C, Dhariwal A, Salker MS, Alauddin M, Zizmare L, Pelzl L, Feger M, Admard J, Casadei N, Föller M, Pachauri V, Park DS, Mak TW, Frick JS, Wallwiener D, Brucker SY, Lang F, Riess O. DJ-1 (Park7) affects the gut microbiome, metabolites and the development of innate lymphoid cells (ILCs). Sci Rep 2020;10:16131. [PMID: 32999308 DOI: 10.1038/s41598-020-72903-w] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
54 Cardinal T, Bergeron KF, Soret R, Souchkova O, Faure C, Guillon A, Pilon N. Male-biased aganglionic megacolon in the TashT mouse model of Hirschsprung disease involves upregulation of p53 protein activity and Ddx3y gene expression. PLoS Genet 2020;16:e1009008. [PMID: 32898154 DOI: 10.1371/journal.pgen.1009008] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
55 Nanthakumaran S, Sridharan S, Somagutta MR, Arnold AA, May V, Pagad S, Malik BH. The Gut-Brain Axis and Its Role in Depression. Cureus 2020;12:e10280. [PMID: 33042715 DOI: 10.7759/cureus.10280] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
56 Galet B, Cheval H, Ravassard P. Patient-Derived Midbrain Organoids to Explore the Molecular Basis of Parkinson's Disease. Front Neurol 2020;11:1005. [PMID: 33013664 DOI: 10.3389/fneur.2020.01005] [Cited by in Crossref: 15] [Cited by in F6Publishing: 18] [Article Influence: 7.5] [Reference Citation Analysis]
57 Bhattarai Y, Kashyap PC. Parkinson's disease: Are gut microbes involved? Am J Physiol Gastrointest Liver Physiol 2020;319:G529-40. [PMID: 32877215 DOI: 10.1152/ajpgi.00058.2020] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
58 Rideout HJ, Chartier-Harlin MC, Fell MJ, Hirst WD, Huntwork-Rodriguez S, Leyns CEG, Mabrouk OS, Taymans JM. The Current State-of-the Art of LRRK2-Based Biomarker Assay Development in Parkinson's Disease. Front Neurosci 2020;14:865. [PMID: 33013290 DOI: 10.3389/fnins.2020.00865] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 7.5] [Reference Citation Analysis]
59 Sanchez JMS, McNally JS, Cortez MM, Hemp J, Pace LA, Clardy SL. Neuroimmunogastroenterology: At the Interface of Neuroimmunology and Gastroenterology. Front Neurol 2020;11:787. [PMID: 32849234 DOI: 10.3389/fneur.2020.00787] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
60 Zheng H, Shi C, Luo H, Fan L, Yang Z, Hu X, Zhang Z, Zhang S, Hu Z, Fan Y, Yang J, Mao C, Xu Y. α-Synuclein in Parkinson's Disease: Does a Prion-Like Mechanism of Propagation from Periphery to the Brain Play a Role? Neuroscientist 2021;27:367-87. [PMID: 32729773 DOI: 10.1177/1073858420943180] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
61 Harsanyiova J, Buday T, Kralova Trancikova A. Parkinson's Disease and the Gut: Future Perspectives for Early Diagnosis. Front Neurosci 2020;14:626. [PMID: 32625058 DOI: 10.3389/fnins.2020.00626] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
62 Tyutina RR, Pilipovich AA, Golubev VL, Danilov AB. Microbiota and Parkinson's disease (overview). Medicinskij alfavit 2020. [DOI: 10.33667/2078-5631-2020-1-10-14] [Reference Citation Analysis]
63 Wang YB, de Lartigue G, Page AJ. Dissecting the Role of Subtypes of Gastrointestinal Vagal Afferents. Front Physiol 2020;11:643. [PMID: 32595525 DOI: 10.3389/fphys.2020.00643] [Cited by in Crossref: 27] [Cited by in F6Publishing: 30] [Article Influence: 13.5] [Reference Citation Analysis]
64 Gries M, Christmann A, Schulte S, Weyland M, Rommel S, Martin M, Baller M, Röth R, Schmitteckert S, Unger M, Liu Y, Sommer F, Mühlhaus T, Schroda M, Timmermans J, Pintelon I, Rappold GA, Britschgi M, Lashuel H, Menger MD, Laschke MW, Niesler B, Schäfer K. Functional and molecular early enteric biomarkers for Parkinson’s disease in mice and men.. [DOI: 10.1101/2020.06.06.136556] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
65 Tataru CA, David MM. Decoding the language of microbiomes using word-embedding techniques, and applications in inflammatory bowel disease. PLoS Comput Biol 2020;16:e1007859. [PMID: 32365061 DOI: 10.1371/journal.pcbi.1007859] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
66 Cabezudo D, Baekelandt V, Lobbestael E. Multiple-Hit Hypothesis in Parkinson's Disease: LRRK2 and Inflammation. Front Neurosci 2020;14:376. [PMID: 32410948 DOI: 10.3389/fnins.2020.00376] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 13.0] [Reference Citation Analysis]
67 Pereira A. Long-Term Neurological Threats of COVID-19: A Call to Update the Thinking About the Outcomes of the Coronavirus Pandemic. Front Neurol. 2020;11:308. [PMID: 32362868 DOI: 10.3389/fneur.2020.00308] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 15.0] [Reference Citation Analysis]
68 Cervellati C, Trentini A, Pecorelli A, Valacchi G. Inflammation in Neurological Disorders: The Thin Boundary Between Brain and Periphery. Antioxid Redox Signal 2020;33:191-210. [PMID: 32143546 DOI: 10.1089/ars.2020.8076] [Cited by in Crossref: 33] [Cited by in F6Publishing: 37] [Article Influence: 16.5] [Reference Citation Analysis]
69 Hsieh TH, Kuo CW, Hsieh KH, Shieh MJ, Peng CW, Chen YC, Chang YL, Huang YZ, Chen CC, Chang PK, Chen KY, Chen HY. Probiotics Alleviate the Progressive Deterioration of Motor Functions in a Mouse Model of Parkinson's Disease. Brain Sci 2020;10:E206. [PMID: 32244769 DOI: 10.3390/brainsci10040206] [Cited by in Crossref: 48] [Cited by in F6Publishing: 55] [Article Influence: 24.0] [Reference Citation Analysis]
70 Mendonça IP, Duarte-Silva E, Chaves-Filho AJM, Andrade da Costa BLDS, Peixoto CA. Neurobiological findings underlying depressive behavior in Parkinson's disease: A review. Int Immunopharmacol 2020;83:106434. [PMID: 32224442 DOI: 10.1016/j.intimp.2020.106434] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 5.5] [Reference Citation Analysis]
71 Endres K. Amyloidogenic Peptides in Human Neuro-Degenerative Diseases and in Microorganisms: A Sorrow Shared Is a Sorrow Halved? Molecules 2020;25:E925. [PMID: 32093040 DOI: 10.3390/molecules25040925] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
72 Hegelmaier T, Lebbing M, Duscha A, Tomaske L, Tönges L, Holm JB, Bjørn Nielsen H, Gatermann SG, Przuntek H, Haghikia A. Interventional Influence of the Intestinal Microbiome Through Dietary Intervention and Bowel Cleansing Might Improve Motor Symptoms in Parkinson's Disease. Cells 2020;9:E376. [PMID: 32041265 DOI: 10.3390/cells9020376] [Cited by in Crossref: 32] [Cited by in F6Publishing: 33] [Article Influence: 16.0] [Reference Citation Analysis]
73 de Lucena JD, Gadelha-filho CVJ, da Costa RO, de Araújo DP, Lima FAV, Neves KRT, de Barros Viana GS. L-linalool exerts a neuroprotective action on hemiparkinsonian rats. Naunyn-Schmiedeberg's Arch Pharmacol 2020;393:1077-88. [DOI: 10.1007/s00210-019-01793-1] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
74 Jackson A, Forsyth CB, Shaikh M, Voigt RM, Engen PA, Ramirez V, Keshavarzian A. Diet in Parkinson's Disease: Critical Role for the Microbiome. Front Neurol 2019;10:1245. [PMID: 31920905 DOI: 10.3389/fneur.2019.01245] [Cited by in Crossref: 56] [Cited by in F6Publishing: 58] [Article Influence: 18.7] [Reference Citation Analysis]
75 O'Carroll A, Coyle J, Gambin Y. Prions and Prion-like assemblies in neurodegeneration and immunity: The emergence of universal mechanisms across health and disease. Semin Cell Dev Biol 2020;99:115-30. [PMID: 31818518 DOI: 10.1016/j.semcdb.2019.11.012] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 4.7] [Reference Citation Analysis]
76 Desplats P, Gutierrez AM, Antonelli MC, Frasch MG. Microglial memory of early life stress and inflammation: Susceptibility to neurodegeneration in adulthood. Neurosci Biobehav Rev 2020;117:232-42. [PMID: 31703966 DOI: 10.1016/j.neubiorev.2019.10.013] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 5.7] [Reference Citation Analysis]
77 Cerovic M, Forloni G, Balducci C. Neuroinflammation and the Gut Microbiota: Possible Alternative Therapeutic Targets to Counteract Alzheimer's Disease? Front Aging Neurosci 2019;11:284. [PMID: 31680937 DOI: 10.3389/fnagi.2019.00284] [Cited by in Crossref: 63] [Cited by in F6Publishing: 64] [Article Influence: 21.0] [Reference Citation Analysis]
78 Singh Y, Trautwein C, Dhariwal A, Salker MS, Alauddin M, Zigmare L, Pelzl L, Feger M, Matthes J, Casadei N, Föller M, Pachauri V, Park DS, Mak TW, Frick JS, Wallwiener D, Brucker SY, Lang F, Riess O. DJ-1 (Park7) affects the gut microbiome, metabolites and development of Innate Lymphoid cells (ILCs).. [DOI: 10.1101/776005] [Reference Citation Analysis]
79 da Cruz Moreira-Junior E. Hyper-serotonergic state determines onset and progression of idiopathic Parkinson's disease. Med Hypotheses 2019;133:109399. [PMID: 31542611 DOI: 10.1016/j.mehy.2019.109399] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
80 Tataru CA, David MM. Decoding the Language of Microbiomes: Leveraging Patterns in 16S Public Data using Word-Embedding Techniques and Applications in Inflammatory Bowel Disease.. [DOI: 10.1101/748152] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
81 Gazerani P. Probiotics for Parkinson's Disease. Int J Mol Sci 2019;20:E4121. [PMID: 31450864 DOI: 10.3390/ijms20174121] [Cited by in Crossref: 58] [Cited by in F6Publishing: 65] [Article Influence: 19.3] [Reference Citation Analysis]